HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 70 filers reported holding HUMACYTE INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $388,313 | +82.1% | 132,530 | +77.8% | 0.00% | – |
Q2 2023 | $213,210 | +9.7% | 74,549 | +18.6% | 0.00% | – |
Q1 2023 | $194,309 | +65.6% | 62,883 | +13.1% | 0.00% | – |
Q4 2022 | $117,303 | -49.9% | 55,594 | -22.5% | 0.00% | – |
Q3 2022 | $234,000 | +69.6% | 71,758 | +67.3% | 0.00% | – |
Q2 2022 | $138,000 | -79.6% | 42,903 | -55.3% | 0.00% | – |
Q1 2022 | $678,000 | +20.4% | 95,966 | +23.5% | 0.00% | – |
Q4 2021 | $563,000 | – | 77,685 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
York Capital Management Global Advisors, LLC | 2,291,397 | $16,177,000 | 4.71% |
Endowment Wealth Management, Inc. | 96,618 | $682,000 | 0.72% |
JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 36,171 | $255,000 | 0.24% |
Prescott General Partners LLC | 625,100 | $4,413,000 | 0.20% |
CenterBook Partners LP | 45,752 | $323,000 | 0.12% |
Gladstone Institutional Advisory LLC | 144,867 | $1,023 | 0.07% |
Exos Asset Management LLC | 18,609 | $131,000 | 0.06% |
Sciencast Management LP | 26,300 | $182,000 | 0.04% |
Y-Intercept (Hong Kong) Ltd | 17,125 | $121,000 | 0.03% |
Kovack Advisors, Inc. | 31,500 | $222,000 | 0.02% |